J. McMannis

1.4k total citations
41 papers, 1.0k citations indexed

About

J. McMannis is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, J. McMannis has authored 41 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 16 papers in Oncology and 16 papers in Immunology. Recurrent topics in J. McMannis's work include Hematopoietic Stem Cell Transplantation (17 papers), Immunotherapy and Immune Responses (10 papers) and Immune Cell Function and Interaction (7 papers). J. McMannis is often cited by papers focused on Hematopoietic Stem Cell Transplantation (17 papers), Immunotherapy and Immune Responses (10 papers) and Immune Cell Function and Interaction (7 papers). J. McMannis collaborates with scholars based in United States, Israel and Canada. J. McMannis's co-authors include Marcos de Lima, Safa Karandish, Richard E. Champlin, Elizabeth J. Shpall, Richard I. Fisher, T. Sadeghi, Donald P. Braun, Stephen P. Creekmore, Krishna V. Komanduri and Hui Yang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

J. McMannis

41 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. McMannis United States 15 535 376 360 300 242 41 1.0k
R. J. Berenson United States 9 780 1.5× 377 1.0× 218 0.6× 230 0.8× 163 0.7× 21 1.1k
Joan García‐López Spain 14 510 1.0× 263 0.7× 337 0.9× 210 0.7× 259 1.1× 20 1.1k
Jean Hendy Australia 9 743 1.4× 615 1.6× 222 0.6× 426 1.4× 320 1.3× 11 1.3k
Barbara Bambach United States 11 623 1.2× 298 0.8× 338 0.9× 208 0.7× 196 0.8× 13 922
Alison Rice Australia 17 433 0.8× 258 0.7× 373 1.0× 248 0.8× 429 1.8× 50 1.2k
Remco M. Hoogenboezem Netherlands 20 514 1.0× 350 0.9× 271 0.8× 225 0.8× 530 2.2× 51 1.2k
EF Srour United States 16 849 1.6× 491 1.3× 307 0.9× 279 0.9× 288 1.2× 25 1.3k
Beatrice Del Papa Italy 16 318 0.6× 523 1.4× 467 1.3× 252 0.8× 290 1.2× 32 1.1k
D. Soligo Italy 13 449 0.8× 175 0.5× 257 0.7× 211 0.7× 471 1.9× 20 1.1k
H.-D. Kleine Germany 8 433 0.8× 289 0.8× 295 0.8× 141 0.5× 174 0.7× 16 891

Countries citing papers authored by J. McMannis

Since Specialization
Citations

This map shows the geographic impact of J. McMannis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. McMannis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. McMannis more than expected).

Fields of papers citing papers by J. McMannis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. McMannis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. McMannis. The network helps show where J. McMannis may publish in the future.

Co-authorship network of co-authors of J. McMannis

This figure shows the co-authorship network connecting the top 25 collaborators of J. McMannis. A scholar is included among the top collaborators of J. McMannis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. McMannis. J. McMannis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schuster, Stephen J., Chitra Hosing, Elizabeth J. Shpall, et al.. (2011). Adoptive immunotherapy with autologous CD3/CD28-costimulated T cells after fludarabine-based chemotherapy in patients with chronic lymphocytic leukemia.. Journal of Clinical Oncology. 29(15_suppl). 2557–2557. 1 indexed citations
2.
Ciurea, Stefan O., Rima M. Saliba, Gabriela Rondón, et al.. (2009). Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT. Bone Marrow Transplantation. 45(3). 429–436. 42 indexed citations
3.
Lu, Charles, David J. Stewart, Lin Ji, et al.. (2009). A phase I trial of intravenous therapy with tumor suppressor FUS1-nanoparticles for recurrent/metastatic lung cancer. Journal of Clinical Oncology. 27(15_suppl). e19065–e19065. 5 indexed citations
4.
Lima, Marcos de, J. McMannis, Adrian P. Gee, et al.. (2008). Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial. Bone Marrow Transplantation. 41(9). 771–778. 183 indexed citations
5.
Xing, Dajun, William K. Decker, Simon N. Robinson, et al.. (2006). AML-loaded DC generate Th1-type cellular immune responses in vitro. Cytotherapy. 8(2). 95–104. 7 indexed citations
6.
Yang, Hong, Connie J. Eaves, M. Lima, et al.. (2006). A novel triple purge strategy for eliminating chronic myelogenous leukemia (CML) cells from autografts. Bone Marrow Transplantation. 37(6). 575–582. 6 indexed citations
7.
Parmar, Simrit, Simon N. Robinson, Krishna V. Komanduri, et al.. (2006). Ex vivo expanded umbilical cord blood T cells maintain naive phenotype and TCR diversity. Cytotherapy. 8(2). 149–157. 29 indexed citations
8.
Decker, Walter J., Deyin Xing, Stephen Robinson, et al.. (2006). Double loading of dendritic cell MHC class I and MHC class II with an AML antigen repertoire enhances correlates of T-cell immunity in vitro via amplification of T-cell help. Vaccine. 24(16). 3203–3216. 30 indexed citations
9.
Robinson, Simon N., Jia Q. Ng, Ting Niu, et al.. (2006). Superior ex vivo cord blood expansion following co-culture with bone marrow-derived mesenchymal stem cells. Bone Marrow Transplantation. 37(4). 359–366. 184 indexed citations
10.
Robinson, Sydney K., Ting Niu, Marcos de Lima, et al.. (2005). Ex vivo expansion of umbilical cord blood. Cytotherapy. 7(3). 243–250. 56 indexed citations
11.
Shpall, E.J., et al.. (2004). Transplantation of ex vivo expanded cord blood. Biology of Blood and Marrow Transplantation. 10(10). 738–738. 3 indexed citations
12.
McMannis, J. & Richard Champlin. (2002). Role of the GMP facility for adoptive immunotherapy. Cytotherapy. 4(4). 329–331. 5 indexed citations
13.
Preti, Robert A., H M Lazarus, Jane N. Winter, et al.. (2001). Tumor cell depletion of peripheral blood progenitor cells using positive and positive/negative selection in metastatic breast cancer. Cytotherapy. 3(2). 85–95. 11 indexed citations
14.
Körbling, M, Sergio Giralt, Issa F. Khouri, et al.. (2001). Donor lymphocyte apheresis for adoptive immunotherapy compared with blood stem cell apheresis. Journal of Clinical Apheresis. 16(2). 82–87. 8 indexed citations
15.
LeBlanc, M. M., Jeremy Wally, Safa Karandish, et al.. (1998). Mobilized CD34+ cells selected as autografts in patients with primary light‐chain amyloidosis: rationale and application. Transfusion. 38(1). 60–69. 35 indexed citations
16.
Kenyon, Norma S., Gennaro Selvaggi, Luis A. Fernandez, et al.. (1997). Infusion of class II DIM donor bone marrow enhances islet allograft survival in low-dose CyA treated dogs. Transplantation Proceedings. 29(4). 2189–2189. 2 indexed citations
17.
Kenyon, Norma S., et al.. (1997). Characterization of baboon vertebral body marrow. Transplantation Proceedings. 29(4). 1952–1952. 1 indexed citations
18.
McMannis, J., et al.. (1990). Effects of interleukin 2 on cardiac function in the isolated rat heart.. Journal of Clinical Investigation. 86(3). 845–850. 44 indexed citations
19.
Goldman, J N, et al.. (1988). Effects of Anti-C4 Antibody on Complement Production by Splenic and Peritoneal Macrophages. PubMed. 5(1). 13–26. 3 indexed citations
20.
Ellis, Tom, et al.. (1988). Appearance and phenotypic characterization of circulating Leu 19+ cells in cancer patients receiving recombinant interleukin 2.. PubMed. 48(22). 6597–602. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. J. Berenson Breakdown of academic impact, for papers by Joan García‐López Breakdown of academic impact, for papers by Jean Hendy Breakdown of academic impact, for papers by Barbara Bambach Breakdown of academic impact, for papers by Alison Rice Breakdown of academic impact, for papers by Remco M. Hoogenboezem Breakdown of academic impact, for papers by EF Srour Breakdown of academic impact, for papers by Beatrice Del Papa Breakdown of academic impact, for papers by D. Soligo Breakdown of academic impact, for papers by H.-D. Kleine
Rankless by CCL
2026